What is the Color of Cancer?
Journal Title: Üroonkoloji Bülteni - Year 2017, Vol 16, Issue 1
Abstract
Objective: To investigate the colors that evokes cancer in the patients with prostate, lung and breast cancer, and in healthy controls. Materials and Methods: A visual card in one of the 9 colors (white, red, orange, yellow, green, blue, purple, navy, black) was shown to totally 210 patients diagnosed with lung cancer (LC), prostate cancer (PC) or breast cancer (BC) and 200 healthy participants and the question of “What is the color of cancer?” was asked to them. Disease information of the cancer patients were also recorded. Results: The mean ages of the patient and control groups were 61.54 and 20.49, respectively (p<0.001). While the most preferred color was yellow (24.8%) in the patient group, it was red (39%) in the control group. The patients were divided into three groups according to both type and stage of cancer. While the patients with PC and BC selected yellow color, the patients with LC selected black color. The patients without recurrent and residual diseases preferred yellow, patients with local recurrence preferred red and patients with distant metastasis preferred black colors. Conclusion: While cancer patients selected yellow color which represents positive emotions, the healthy young individuals selected red color which represents negative emotions. However, progressive or aggressive cancer patients selected red and black colors which is associated with negative emotions.
Authors and Affiliations
Volkan Tatlı, Oktay Üçer, Talha Müezzinoğlu
Keywords
Related Articles
- EP ID EP226739
- DOI 10.4274/uob.795
- Views 97
- Downloads 0
A New Era in Metastatic Prostate Cancer: “The Combination of Chemotherapy and Hormonal Treatment as Initial Treatment”
In recent years, studies have been reported about the combination of androgen deprivation therapy (ADT) and different chemotherapy modalities as the initial therapy in newly-diagnosed patients with hormone-sensitive meta...
Neutropenic Fever, Skin and Eye Toxicities Develops During Docetaxel Treatment in Metastatic Prostate Cancer: A Case Report
Prostate cancer is one of the most common tumors in men. Docetaxel and prednisone treatment are accepted as standard therapy in castration-resistant prostate cancer patients. Docetaxel is a chemotherapeutic drug of the t...
Additional Surgical Procedures During Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients with Nonseminomatous Testicular Tumor
Objective: Retroperitoneal lymph node dissection (RLND) is frequently performed in non-seminomatous testicular tumor (TT) patients, especially in cases who have radiological residual mass despite normal tumor markers aft...
The Presence and Thickness of Pseudocapsule after Partial Nephrectomy in Renal Cell Carcinoma
Objective: In this study, we aimed to evaluate the presence and thickness of pseudocapsule after partial nephrectomy in renal cell carcinoma (RCC) cases. Materials and Methods: A total of 100 patients who were admitted t...
Rare Benign and Uncertain Malignant Potential Tumors of Bladder: Review of the Literature
The most common primary bladder cancer are transitional cell (urothelial) carcinomas. However, there are several uncommon but significant bladder lesions that must be differentiated from urothelial carcinomas. These blad...